Devonian Health Group Inc.
DVHGF
$10.65
$6.38149.65%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 359.60K | 758.30K | 930.60K | 5.18M | 6.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 359.60K | 758.30K | 930.60K | 5.18M | 6.21M |
| Cost of Revenue | 335.10K | 376.30K | 3.70K | 3.28M | 4.37M |
| Gross Profit | 24.60K | 382.00K | 926.90K | 1.90M | 1.84M |
| SG&A Expenses | 2.77M | 1.18M | 978.10K | 1.46M | 1.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 24.50K | 23.80K | 23.10K | 22.00K | 22.60K |
| Total Operating Expenses | 2.02M | 1.91M | 1.23M | 5.20M | 6.04M |
| Operating Income | -1.66M | -1.15M | -301.50K | -21.30K | 170.80K |
| Income Before Tax | -1.65M | -1.12M | -282.20K | -3.38M | 147.30K |
| Income Tax Expenses | -- | -- | -9.20K | -- | 307.50K |
| Earnings from Continuing Operations | -1.65M | -1.12M | -272.90K | -3.38M | -160.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.65M | -1.12M | -272.90K | -3.38M | -160.30K |
| EBIT | -1.66M | -1.15M | -301.50K | -21.30K | 170.80K |
| EBITDA | -1.63M | -1.12M | -276.20K | 41.40K | 233.80K |
| EPS Basic | -1.19 | -0.41 | -0.11 | -1.37 | -0.06 |
| Normalized Basic EPS | -0.75 | -0.25 | -0.07 | 0.01 | 0.04 |
| EPS Diluted | -1.19 | -0.41 | -0.11 | -1.37 | -0.06 |
| Normalized Diluted EPS | -0.75 | -0.25 | -0.07 | 0.01 | 0.04 |
| Average Basic Shares Outstanding | 5.53M | 2.76M | 2.47M | 2.47M | 2.47M |
| Average Diluted Shares Outstanding | 5.53M | 2.76M | 2.47M | 2.67M | 2.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |